CS
COGT icon

Candriam SCA’s Cogent Biosciences COGT Stock Holding History

Candriam SCA’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.4M Buy
1,516,297
+219,822
+17% +$8.12M 0.3% 74
2025
Q4 		$46.1M Buy
1,296,475
+342,266
+36% +$9.62M 0.23% 97
2025
Q3 		$13.7M Buy
954,209
+526,867
+123% +$6.24M 0.07% 225
2025
Q2 		$3.07M Buy
+427,342
New +$2.37M 0.02% 429
2024
Q1 		– Sell
-232,487
Closed -$1.37M – 703
2023
Q4 		$1.37M Sell
232,487
-545,000
-70% -$4.18M 0.01% 542
2023
Q3 		$7.53M Buy
777,487
+5,000
+0.6% +$59.3K 0.05% 261
2023
Q2 		$9.15M Sell
772,487
-164,654
-18% -$1.89M 0.07% 256
2023
Q1 		$9.31M Sell
937,141
-60,000
-6% -$767K 0.06% 267
2022
Q4 		$11.5M Sell
997,141
-154,361
-13% -$1.91M 0.08% 244
2022
Q3 		$17.2M Sell
1,151,502
-99,387
-8% -$1.36M 0.12% 182
2022
Q2 		$11.3M Sell
1,250,889
-502,091
-29% -$3.43M 0.09% 209
2022
Q1 		$13.1M Sell
1,752,980
-112,792
-6% -$785K 0.09% 216
2021
Q4 		$16M Sell
1,865,772
-61,477
-3% -$534K 0.1% 203
2021
Q3 		$16.2M Buy
1,927,249
+16,529
+0.9% +$127K 0.11% 204
2021
Q2 		$15.5M Buy
1,910,720
+1,435,911
+302% +$12.1M 0.11% 224
2021
Q1 		$5.12M Buy
474,809
+79
+0% +$761 0.04% 369
2020
Q4 		$5.33M Buy
+474,730
New +$5.22M 0.04% 378

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Candriam SCA's COGT Position: Q1 2026 in Review

Candriam SCA increased its Cogent Biosciences (COGT) stake by 17% in Q1 2026, buying an estimated $8.12M and bringing the position to 1,516,297 shares worth $58.4M. The position accounts for 0.3% of the portfolio, ranked #74.

Candriam SCA first reported a position in COGT in Q4 2020 and has held it in 17 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Candriam SCA held 1,516,297 shares of Cogent Biosciences worth $58.4M as of Q1 2026.
  • Candriam SCA bought 219,822 Cogent Biosciences shares in Q1 2026, an estimated $8.12M.
  • Cogent Biosciences made up 0.3% of Candriam SCA's portfolio in Q1 2026, its #74 holding.
  • Candriam SCA first reported a position in Cogent Biosciences in Q4 2020 and has held it in 17 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.